Cite
HARVARD Citation
Nakamura, T. et al. (2017). Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study). Osteoporosis international. 28 (1), pp. 389-398. [Online].